1. Home
  2. RAYA vs PYPD Comparison

RAYA vs PYPD Comparison

Compare RAYA & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Erayak Power Solution Group Inc.

RAYA

Erayak Power Solution Group Inc.

HOLD

Current Price

$4.41

Market Cap

4.2M

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$3.93

Market Cap

66.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAYA
PYPD
Founded
2019
2008
Country
China
Israel
Employees
N/A
N/A
Industry
Metal Fabrications
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
66.2M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
RAYA
PYPD
Price
$4.41
$3.93
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$12.00
AVG Volume (30 Days)
32.8K
87.0K
Earning Date
04-17-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,101,325.00
N/A
Revenue This Year
$20.95
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.78
N/A
52 Week Low
$3.13
$2.30
52 Week High
$736.99
$4.07

Technical Indicators

Market Signals
Indicator
RAYA
PYPD
Relative Strength Index (RSI) 49.89 53.86
Support Level $3.95 $3.89
Resistance Level $4.50 $4.05
Average True Range (ATR) 0.46 0.10
MACD -0.02 -0.01
Stochastic Oscillator 27.92 20.83

Price Performance

Historical Comparison
RAYA
PYPD

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: